tradingkey.logo
tradingkey.logo
Buscar

Masimo Corp

MASI
Añadir a la lista de seguimiento
179.965USD
0.0000.00%
Horarios del mercado ETCotizaciones retrasadas 15 min
9.42BCap. mercado
125.98P/E TTM

Más Datos de Masimo Corp Compañía

Masimo Corporation is a global medical technology company that develops and produces a wide range of monitoring technologies, including measurements, sensors, patient monitors, automation and connectivity solutions. The Company’s healthcare products and patient monitoring solutions generally incorporate a monitor or circuit board, proprietary single-patient use or reusable sensors, software and/or cables. It primarily sells its healthcare products to hospitals, emergency medical service providers, home care providers, physician offices, veterinarians, long-term care facilities. Its measurement technologies include Measure-through Motion and Low Perfusion pulse oximetry, known as Masimo Signal Extraction Technology (SET) pulse oximetry, and advanced rainbow Pulse CO-Oximetry parameters such as noninvasive hemoglobin (SpHb), alongside many other modalities, including brain function monitoring, hemodynamic monitoring, regional oximetry, capnography and gas monitoring, and others.

Información de Masimo Corp

Símbolo de cotizaciónMASI
Nombre de la empresaMasimo Corp
Fecha de salida a bolsaAug 08, 2007
Director ejecutivoSzyman (Catherine M)
Número de empleados3600
Tipo de seguridadOrdinary Share
Fin del año fiscalAug 08
Dirección52 Discovery
CiudadIRVINE
Bolsa de valoresNASDAQ OMX - NASDAQ BASIC
PaísUnited States of America
Código postal92618
Teléfono19492977000
Sitio Webhttps://www.masimo.com/
Símbolo de cotizaciónMASI
Fecha de salida a bolsaAug 08, 2007
Director ejecutivoSzyman (Catherine M)

Ejecutivos de Masimo Corp

Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Mr. Blair Tripodi
Mr. Blair Tripodi
Chief Operating Officer - Consumer Division
Chief Operating Officer - Consumer Division
15.54K
+44.56%
Mr. Quentin Koffey
Mr. Quentin Koffey
Lead Independent Vice Chairman of the Board
Lead Independent Vice Chairman of the Board
4.24K
--
Mr. Eli Kammerman
Mr. Eli Kammerman
Investor Relations Officer
Investor Relations Officer
--
--
Mr. Micah Wesley Young
Mr. Micah Wesley Young
Chief Financial Officer, Executive Vice President
Chief Financial Officer, Executive Vice President
--
--
Ms. Michelle M. Brennan
Ms. Michelle M. Brennan
Chairman of the Board
Chairman of the Board
--
--
Dr. Darlene Solomon
Dr. Darlene Solomon
Independent Director
Independent Director
--
--
Mr. Timothy J. (Tim) Scannell
Mr. Timothy J. (Tim) Scannell
Independent Director
Independent Director
--
--
Ms. Wendy E. Lane
Ms. Wendy E. Lane
Independent Director
Independent Director
--
--
Ms. Catherine M. (Katie) Szyman
Ms. Catherine M. (Katie) Szyman
Chief Executive Officer, Director
Chief Executive Officer, Director
--
--
Mr. Tim Benner
Mr. Tim Benner
Chief Marketing and Strategy Officer
Chief Marketing and Strategy Officer
--
--
Ver más
Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Mr. Blair Tripodi
Mr. Blair Tripodi
Chief Operating Officer - Consumer Division
Chief Operating Officer - Consumer Division
15.54K
+44.56%
Mr. Quentin Koffey
Mr. Quentin Koffey
Lead Independent Vice Chairman of the Board
Lead Independent Vice Chairman of the Board
4.24K
--
Mr. Eli Kammerman
Mr. Eli Kammerman
Investor Relations Officer
Investor Relations Officer
--
--
Mr. Micah Wesley Young
Mr. Micah Wesley Young
Chief Financial Officer, Executive Vice President
Chief Financial Officer, Executive Vice President
--
--
Ms. Michelle M. Brennan
Ms. Michelle M. Brennan
Chairman of the Board
Chairman of the Board
--
--
Dr. Darlene Solomon
Dr. Darlene Solomon
Independent Director
Independent Director
--
--

Preguntas frecuentes

¿Quiénes son los cinco principales accionistas de Masimo Corp?

Los cinco principales accionistas de Masimo Corp son: Mr. Blair Tripodi

¿Cuántas instituciones poseen acciones de Masimo Corp (MASI)?

A fecha de 2026Q1, 853 instituciones poseen acciones de Masimo Corp, con un valor de mercado combinado de aproximadamente 57.76M, lo que representa el 110.30% del total de acciones. En comparación con el 2025Q4, el accionariado institucional ha aumentado en -5596875.00.
KeyAI